Van der Heijde D, et al. Ixekizumab Significantly Improves Signs, Symptoms, and Spinal Inflammation of Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 16-Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial. ACR 2018, abstract 1864.
Deucravacitinib verbetert patiëntgerapporteerde uitkomsten bij actieve PsA
jun 2024 | Arthritis psoriatica